ArticleOncotarget2017

Comparison of two transarterial chemoembolization regimens in patients with unresectable hepatocellular carcinoma: raltitrexed plus oxaliplatin

Wei Cui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.